pHetalSafe is a pioneering startup with the mission of advancing fetal monitoring during labor and delivery to ensure safer childbirth. The company's innovative approach harnesses the potential of biophotonics to develop a ground-breaking solution capable of measuring fetal lactate & pH in real-time, enabling an objective assessment of fetal distress and suspected fetal hypoxia during childbirth.
Operating in the Medical Devices sector, pHetalSafe has garnered significant support, including a grant investment secured on 13 March 2023 from Enterprise Ireland. This backing underscores the potential and promise that the startup holds in addressing critical needs within the maternal healthcare space.